23.78 USD
-0.21 (-0.88%)
CPRX gets a fundamental rating of 8 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. CPRX has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. CPRX is evaluated to be cheap and growing strongly. This does not happen too often! With these ratings, CPRX could be worth investigating further for value and growth and quality investing!.
1. Profitability
1.1 Basic Checks
- CPRX had positive earnings in the past year.
- CPRX had a positive operating cash flow in the past year.
- CPRX had positive earnings in each of the past 5 years.
- In the past 5 years CPRX always reported a positive cash flow from operatings.
1.2 Ratios
- The Return On Assets of CPRX (20.69%) is better than 97.14% of its industry peers.
- Looking at the Return On Equity, with a value of 23.65%, CPRX belongs to the top of the industry, outperforming 96.76% of the companies in the same industry.
- CPRX has a Return On Invested Capital of 21.23%. This is amongst the best in the industry. CPRX outperforms 97.90% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for CPRX is above the industry average of 18.07%.
- The 3 year average ROIC (20.37%) for CPRX is below the current ROIC(21.23%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.69% | ||
| ROE | 23.65% | ||
| ROIC | 21.23% |
ROA(3y)18.85%
ROA(5y)22.43%
ROE(3y)22.87%
ROE(5y)26.38%
ROIC(3y)20.37%
ROIC(5y)19.67%
1.3 Margins
- Looking at the Profit Margin, with a value of 37.64%, CPRX belongs to the top of the industry, outperforming 96.76% of the companies in the same industry.
- In the last couple of years the Profit Margin of CPRX has remained more or less at the same level.
- CPRX has a Operating Margin of 44.78%. This is amongst the best in the industry. CPRX outperforms 99.43% of its industry peers.
- CPRX's Operating Margin has improved in the last couple of years.
- Looking at the Gross Margin, with a value of 85.68%, CPRX belongs to the top of the industry, outperforming 88.38% of the companies in the same industry.
- In the last couple of years the Gross Margin of CPRX has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 44.78% | ||
| PM (TTM) | 37.64% | ||
| GM | 85.68% |
OM growth 3Y2.16%
OM growth 5Y5%
PM growth 3Y5.91%
PM growth 5Y1.34%
GM growth 3Y0.61%
GM growth 5Y0.11%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CPRX is creating value.
- The number of shares outstanding for CPRX has been increased compared to 1 year ago.
- The number of shares outstanding for CPRX has been increased compared to 5 years ago.
- There is no outstanding debt for CPRX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- An Altman-Z score of 16.25 indicates that CPRX is not in any danger for bankruptcy at the moment.
- With an excellent Altman-Z score value of 16.25, CPRX belongs to the best of the industry, outperforming 87.05% of the companies in the same industry.
- There is no outstanding debt for CPRX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 16.25 |
ROIC/WACC2.39
WACC8.88%
2.3 Liquidity
- CPRX has a Current Ratio of 6.62. This indicates that CPRX is financially healthy and has no problem in meeting its short term obligations.
- CPRX's Current ratio of 6.62 is fine compared to the rest of the industry. CPRX outperforms 67.62% of its industry peers.
- A Quick Ratio of 6.40 indicates that CPRX has no problem at all paying its short term obligations.
- CPRX has a Quick ratio of 6.40. This is in the better half of the industry: CPRX outperforms 66.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.62 | ||
| Quick Ratio | 6.4 |
3. Growth
3.1 Past
- CPRX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 45.76%, which is quite impressive.
- The Earnings Per Share has been growing by 34.29% on average over the past years. This is a very strong growth
- CPRX shows a strong growth in Revenue. In the last year, the Revenue has grown by 25.56%.
- CPRX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 36.89% yearly.
EPS 1Y (TTM)45.76%
EPS 3Y52.41%
EPS 5Y34.29%
EPS Q2Q%20%
Revenue 1Y (TTM)25.56%
Revenue growth 3Y51.72%
Revenue growth 5Y36.89%
Sales Q2Q%15.31%
3.2 Future
- The Earnings Per Share is expected to grow by 26.80% on average over the next years. This is a very strong growth
- CPRX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.21% yearly.
EPS Next Y24.97%
EPS Next 2Y18.55%
EPS Next 3Y12.53%
EPS Next 5Y26.8%
Revenue Next Year19.48%
Revenue Next 2Y13.05%
Revenue Next 3Y11.23%
Revenue Next 5Y11.21%
3.3 Evolution
- Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 13.83 indicates a correct valuation of CPRX.
- 96.76% of the companies in the same industry are more expensive than CPRX, based on the Price/Earnings ratio.
- CPRX is valuated rather cheaply when we compare the Price/Earnings ratio to 27.25, which is the current average of the S&P500 Index.
- Based on the Price/Forward Earnings ratio of 12.92, the valuation of CPRX can be described as correct.
- Based on the Price/Forward Earnings ratio, CPRX is valued cheaply inside the industry as 96.76% of the companies are valued more expensively.
- The average S&P500 Price/Forward Earnings ratio is at 25.98. CPRX is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.83 | ||
| Fwd PE | 12.92 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CPRX indicates a rather cheap valuation: CPRX is cheaper than 98.29% of the companies listed in the same industry.
- Based on the Price/Free Cash Flow ratio, CPRX is valued cheaper than 97.52% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.46 | ||
| EV/EBITDA | 7.61 |
4.3 Compensation for Growth
- CPRX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- CPRX has an outstanding profitability rating, which may justify a higher PE ratio.
- A more expensive valuation may be justified as CPRX's earnings are expected to grow with 12.53% in the coming years.
PEG (NY)0.55
PEG (5Y)0.4
EPS Next 2Y18.55%
EPS Next 3Y12.53%
5. Dividend
5.1 Amount
- No dividends for CPRX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
CATALYST PHARMACEUTICALS INC / CPRX FAQ
What is the ChartMill fundamental rating of CATALYST PHARMACEUTICALS INC (CPRX) stock?
ChartMill assigns a fundamental rating of 8 / 10 to CPRX.
What is the valuation status for CPRX stock?
ChartMill assigns a valuation rating of 8 / 10 to CATALYST PHARMACEUTICALS INC (CPRX). This can be considered as Undervalued.
Can you provide the profitability details for CATALYST PHARMACEUTICALS INC?
CATALYST PHARMACEUTICALS INC (CPRX) has a profitability rating of 9 / 10.
What is the expected EPS growth for CATALYST PHARMACEUTICALS INC (CPRX) stock?
The Earnings per Share (EPS) of CATALYST PHARMACEUTICALS INC (CPRX) is expected to grow by 24.97% in the next year.